Monthly Prescribing Reference

FDA Approves Omvoh Single-Injection Maintenance Regimen for Ulcerative Colitis

According to Lilly, the single-injection, citrate-free, maintenance dose will be available in the US as a prefilled pen or prefilled syringe in early 2026. The Food and Drug Administration (FDA) has ...
Yahoo Finance

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...
Pharm Exec

FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis

The FDA approved a once-monthly, single-injection regimen for Omvoh, enhancing convenience for UC patients. Omvoh, an IL-23p19 antagonist, offers bioequivalent efficacy to the previous two-injection ...
Rutland Herald

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis | Press Releases | rutlandherald.com

Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing will be available for U.S. patients ...
Finanznachrichten

Eli Lilly and Company: Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

"A single monthly injection of Omvoh gives patients a regimen that's easier to manage alongside the unpredictability of living with ulcerative colitis." The Omvoh single-injection, citrate-free ...